Cardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In Russia
VANCOUVER, Dec. 12, 2017 -- (Healthcare Sales & Marketing Network) - Cardiome Pharma Corp. (NASDAQ: CRME / TSX:COM), a revenue-generating, specialty pharmaceutical company focused on commercializing patent-protected hospital drugs, today announced that it... Biopharmaceuticals, Cardiology, Licensing Cardiome Pharma, ZAO Firma Euroservice, Correvio, Aggrastat (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 12, 2017 Category: Pharmaceuticals Source Type: news

DARZALEX(R) (daratumumab) Combination Regimen Significantly Improved Outcomes for Newly Diagnosed Multiple Myeloma Patients who are Transplant Ineligible
Phase 3 ALCYONE data showed DARZALEX in combination with bortezomib, melphalan and prednisone meaningfully improved progression-free survival and response rates Data featured as late-breaker at ASH 2017 (Abstract #LBA-4) and published in the New England... Biopharmaceuticals, Oncology Janssen Biotech, DARZALEX, daratumumab, multiple myeloma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 12, 2017 Category: Pharmaceuticals Source Type: news

Eyevensys Appoints Dr. Patricia Zilliox as Chief Executive Officer
PARIS, December 12, 2017 -- (Healthcare Sales & Marketing Network) -- Eyevensys, a clinical stage biotech company developing non-viral gene therapies for ophthalmic diseases, today announced the appointment of Dr. Patricia Zilliox as CEO. Dr. Zilliox, ... Biopharmaceuticals, Ophthalmology, Personnel Eyevensys, EyeCET, gene therapy, electro-transfection injection (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 12, 2017 Category: Pharmaceuticals Source Type: news

Mallinckrodt Completes Acquisition of Ocera Therapeutics and OCR-002, Its Proprietary Therapy in Development for Treatment of Hepatic Encephalopathy
STAINES-UPON-THAMES, United Kingdom, Dec. 11, 2017 -- (Healthcare Sales & Marketing Network) -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced it has closed the acquisition of Ocera Therapeutics, a clinica... Biopharmaceuticals, Mergers & Acquisitions Mallinckrodt, Ocera Therapeutics, hepatic encephalopathy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 11, 2017 Category: Pharmaceuticals Source Type: news

Polaryx Therapeutics Receives Orphan Drug Designation From the US FDA for the Treatment of Neuronal Ceroid Lipofuscinoses With PLX-100
PARAMUS, N.J., Dec. 11, 2017 -- (Healthcare Sales & Marketing Network) -- Polaryx Therapeutics, Inc. is a biotech company developing patient-friendly oral small molecule therapeutics for Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL) and other form... Biopharmaceuticals, Neurology, FDA Polaryx Therapeutics, Neuronal Ceroid Lipofuscinoses (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 11, 2017 Category: Pharmaceuticals Source Type: news

OncoTartis Closes $6M Financing Round
Proceeds to Support Clinical Trials of Promising Cancer Treatment BUFFALO, N.Y., Dec. 11, 2017 -- (Healthcare Sales & Marketing Network) -- OncoTartis, Inc., a biotechnology company developing a novel category of anti-cancer drugs, has concluded a $6 m... Biopharmaceuticals, Oncology, Venture Capital OncoTartis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 11, 2017 Category: Pharmaceuticals Source Type: news

Regeneron Announces FDA Acceptance of sBLA Filing for 12-Week Dosing of EYLEA(R) (aflibercept) Injection for Patients with Wet AMD
TARRYTOWN, N.Y., Dec. 11, 2017 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company's supplemental Biologics Licen... Biopharmaceuticals, Ophthalmology, FDA Regeneron Pharmaceuticals, EYLEA, aflibercept, macular degeneration (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 11, 2017 Category: Pharmaceuticals Source Type: news

FDA Accepts Biologics License Application (BLA) to Review Galcanezumab for the Prevention of Migraine in Adults
Galcanezumab is the first of three investigational, non-opioid treatments in Lilly's pain portfolio INDIANAPOLIS, Dec. 11, 2017 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug A... Biopharmaceuticals, FDA Eli Lilly, Galcanezumab, migraine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 11, 2017 Category: Pharmaceuticals Source Type: news

Kimberly Blackwell, M.D., to become Vice President of Early Phase Development and Immuno-oncology at Lilly Oncology
INDIANAPOLIS, Dec. 11, 2017 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) today announced that Kimberly Blackwell, M.D., one of the nation's leading breast cancer researchers, will join Lilly Oncology as vice president of ... Biopharmaceuticals, Oncology, Personnel Eli Lilly (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 11, 2017 Category: Pharmaceuticals Source Type: news

Ardelyx Announces License Agreement with Shanghai Fosun Pharmaceutical Industrial Development Company Limited for Tenapanor in China
Ardelyx to Receive Up to $125 Million in Upfront Payment and Subsequent Milestones FREMONT, Calif., Dec. 11, 2017 -- (Healthcare Sales & Marketing Network) -- Ardelyx, Inc. (NASDAQ: ARDX) today announced that the company has entered into a license agre... Biopharmaceuticals, Gastroenterology, Licensing Ardelyx, Fosun Pharma, tenapanor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 11, 2017 Category: Pharmaceuticals Source Type: news

Stryker announces definitive agreement to acquire Entellus
Kalamazoo, Michigan – December 7, 2017 -- (Healthcare Sales & Marketing Network) -- Stryker Corporation (NYSE: SYK) announced today a definitive merger agreement to acquire Entellus Medical, Inc. (NASDAQ: ENTL) for $24.00 per share, or an equity value of a... Devices, Mergers & Acquisitions Stryker, Entellus Medical, Multi-Sinus Dilation System, Absorbable Nasal Implant (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 8, 2017 Category: Pharmaceuticals Source Type: news

Impax Receives Tentative FDA Approval of Generic Coreg CR(R) (Carvedilol Phosphate) Extended-Release Capsules
BRIDGEWATER, N.J., Dec. 8, 2017 -- (Healthcare Sales & Marketing Network) -- Impax Laboratories, Inc. (NASDAQ: IPXL), a specialty pharmaceutical company, today announced it has received tentative U.S. Food and Drug Administration ("FDA") approva... Biopharmaceuticals, Generics, FDA Impax Laboratories, Coreg CR, carvedilol (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 8, 2017 Category: Pharmaceuticals Source Type: news

VitalConnect Secures Fifth U.S. FDA Clearance for Patient Monitoring Device
The VitalPatch wearable biosensor will include 5-day wear duration in alignment with nation's average hospital stay SAN JOSE, Calif., Dec. 7, 2017 -- (Healthcare Sales & Marketing Network) -- VitalConnect, Inc., a leader in wearable biosensor technolog... Devices, Monitoring, FDA VitalConnect, VitalPatch (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 7, 2017 Category: Pharmaceuticals Source Type: news

John Walsh, M.D. Joins EMD Serono as Vice President of Neurology and Immunology, US Medical Affairs
ROCKLAND, Mass., Dec. 7, 2017 -- (Healthcare Sales & Marketing Network) -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, today announced the appointment of John Walsh, M.D. as Vice President, Neurology ... Biopharmaceuticals, Personnel EMD Serono, Merck KGaA, Rebif, interferon (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 7, 2017 Category: Pharmaceuticals Source Type: news

Aptinyx Bolsters Executive Leadership Team with Appointment of Andy Kidd as Chief Commercial Officer
EVANSTON, Ill., Dec. 7, 2017 -- (Healthcare Sales & Marketing Network) -- Aptinyx Inc., a clinical-stage biopharmaceutical company developing transformative therapies for challenging neurologic disorders, today announced the appointment of Andy Kidd, B.M.... Biopharmaceuticals, Neurology, Personnel Aptinyx, neuropathic pain, PTSD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 7, 2017 Category: Pharmaceuticals Source Type: news

Bioness StimRouter(R) Neuromodulation System Eligible for Increased Medicare Reimbursements
Medicare patients suffering from chronic peripheral nerve pain will have greater access to treatment starting January 1, 2018 VALENCIA, Calif., Dec. 7, 2017 -- (Healthcare Sales & Marketing Network) -- Bioness, Inc., the leading provider of cutting edg... Devices, Neurology, Reimbursement Bioness, StimRouter, Neuromodulation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 7, 2017 Category: Pharmaceuticals Source Type: news

Dr. Aradhana Ghosh Joins Precision Medicine Leader Syapse As Vice President of Oncology
Oncologist-Executive Brings Extensive Medical and Informatics Experience to Rapidly Growing Precision Medicine Company SAN FRANCISCO, Dec. 7, 2017 -- (Healthcare Sales & Marketing Network) -- Syapse, a market leader in precision medicine solutions, ann... Oncology, Personnel Syapse, precision medicine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 7, 2017 Category: Pharmaceuticals Source Type: news

Camber Spine Announces FDA Clearance Of Spira(TM)-C Open Matrix Cervical Interbody
WAYNE, Pa., Dec. 7, 2017 -- (Healthcare Sales & Marketing Network) -- Camber Spine announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its SPIRA™-C Open Matrix Cervical Interbody device, an inno... Devices, Orthopaedic, Neurosurgery, FDA Camber Spine Technologies, SPIRA-C, Open Matrix, Interbody fusion (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 7, 2017 Category: Pharmaceuticals Source Type: news

Epidarex Capital Portfolio Company Harpoon Medical Acquired By Edwards Lifesciences
Acquisition Marks Further Success for the Epidarex Portfolio BETHESDA, Md., Dec. 7, 2017 -- (Healthcare Sales & Marketing Network) -- Epidarex Capital ("Epidarex"), an early-stage, transatlantic life science venture fund, today announced that... Devices, Cardiology, Mergers & Acquisitions Epidarex Capital, Harpoon Medical, Edwards Lifesciences (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 7, 2017 Category: Pharmaceuticals Source Type: news

Metacrine Completes Series B Financing to Advance Best-in-Class FXR Program into Clinical Development
SAN DIEGO, Dec. 7, 2017 -- (Healthcare Sales & Marketing Network) -- Metacrine, Inc., an innovative biotechnology company focused on drug development, today announced it has closed a $22M Series B financing led by new investor New Enterprise Associates (N... Biopharmaceuticals, Venture Capital, Personnel Metacrine, FXR agonist (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 7, 2017 Category: Pharmaceuticals Source Type: news

ImpediMed Launches FDA-Approved SOZO(TM)
Diagnostic Device Aids in Clinical Assessment of Lymphedema CARLSBAD, Calif., Dec. 6, 2017 -- (Healthcare Sales & Marketing Network) -- ImpediMed Limited (ASX: IPD), a global provider of medical technology that non-invasively measures, monitors and man... Devices, Product Launch ImpediMed, SOZO, lymphedema (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 6, 2017 Category: Pharmaceuticals Source Type: news

Viriom Announces New Director Appointment
SAN DIEGO, Dec. 6, 2017 -- (Healthcare Sales & Marketing Network) -- Viriom Inc. is pleased to announce the appointment of Augustine Lawlor as Director of Viriom. Mr. Lawlor brings to Viriom his extensive operating experience in strategic business develo... Biopharmaceuticals, Personnel Viriom (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 6, 2017 Category: Pharmaceuticals Source Type: news

Sirnaomics' Leading siRNA Therapeutic Candidate, STP705, Granted Orphan Designation for Treatment of Cholangiocarcinoma
GAITHERSBURG, Md., Dec. 6, 2017 -- (Healthcare Sales & Marketing Network) -- Sirnaomics, Inc. (www.sirnaomics.com), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that the Office of Orphan Product De... Biopharmaceuticals, Oncology, FDA Sirnaomics, Cholangiocarcinoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 6, 2017 Category: Pharmaceuticals Source Type: news

Varian Halcyon Treatment System Receives ANVISA Registration in Brazil
New advanced cancer treatment system from Varian now available to cancer centers in Brazil PALO ALTO, Calif., Dec. 6, 2017 -- (Healthcare Sales & Marketing Network) -- Further expanding the global availability of its new device for cancer treatment, Va... Devices, Oncology, Regulatory Varian Medical Systems, Halcyon System, IMRT, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 6, 2017 Category: Pharmaceuticals Source Type: news

Third Respiratory Assay Now FDA Cleared on Hologic's New Panther Fusion(R) System
New Assay Detects Adenovirus, Human Metapneumovirus and Rhinovirus Modular Panels, Including Influenza, RSV and Paraflu, Increase Efficiency and Flexibility for the Laboratory MARLBOROUGH, Mass., Dec. 6, 2017 -- (Healthcare Sales & Marketing Network)... Diagnostics, FDA, Product Launch Hologic, Panther Fusion, Adenovirus, Metapneumovirus, Rhinovirus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 6, 2017 Category: Pharmaceuticals Source Type: news

Forty Seven Inc. Receives $5 Million Grant from The California Institute for Regenerative Medicine (CIRM) to Support Ongoing Clinical Trial in Acute Myeloid Leukemia
CIRM grant will support further development of Forty Seven Inc.'s CD47 antibody Hu5F9-G4 in an ongoing second trial for the treatment of Acute Myeloid Leukemia and Myelodysplastic Syndrome MENLO PARK, Calif., Dec. 6, 2017 -- (Healthcare Sales & Marketin... Biopharmaceuticals, Regenerative Medicine, Oncology Forty Seven, acute myeloid leukemia, Myelodysplastic Syndrome, stem cell (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 6, 2017 Category: Pharmaceuticals Source Type: news

Bioniz Therapeutics Appoints Graham Cooper to its Board of Directors
IRVINE, Calif., Dec. 6, 2017 -- (Healthcare Sales & Marketing Network) -- Bioniz Therapeutics, Inc., a clinical stage biopharmaceutical company leading the discovery and development of first-in-class peptide therapeutics that selectively and simultaneousl... Biopharmaceuticals, Personnel Bioniz Therapeutics, cytokine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 6, 2017 Category: Pharmaceuticals Source Type: news

INVOKANA(R) (canagliflozin) Significantly Improved Renal Outcomes and Demonstrated Potential Renal Protective Effects in Patients with Type 2 Diabetes Who Have or Are at Risk for Cardiovascular Disease
Late-breaking renal data from the integrated CANVAS Program presented at the American Society of Nephrology Kidney Week 2017 Annual Meeting RARITAN, N.J. and NEW ORLEANS, Nov. 3, 2017 -- (Healthcare Sales & Marketing Network) -- Janssen Research & Deve... Biopharmaceuticals, Nephrology Janssen, INVOKANA, canagliflozin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 5, 2017 Category: Pharmaceuticals Source Type: news

Lia Diagnostics Announces FDA Clearance Of The First And Only Flushable, Biodegradable Pregnancy Test
PHILADELPHIA, Dec. 5, 2017 -- (Healthcare Sales & Marketing Network) -- Lia Diagnostics, Inc. yesterday announced the U.S. Food and Drug Administration (FDA) 510(k) clearance for over-the-counter use of the Lia Pregnancy Test, the first and only FDA-clear... Diagnostics, FDA Lia Diagnostics, Lia Pregnancy Test (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 5, 2017 Category: Pharmaceuticals Source Type: news

Cocoon Biotech Appoints Dr. Annalisa Jenkins as Executive Chair of the Board
Appointment Further Bolsters Strong Board Which Includes Drs. Colón and Tweed-Kent BOSTON, Dec. 5, 2017 -- (Healthcare Sales & Marketing Network) -- Cocoon Biotech, Inc., a biotechnology company with a broad drug delivery platform and an initial... Biopharmaceuticals, Drug Delivery, Ophthalmology, Personnel Cocoon Biotech, fibroin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 5, 2017 Category: Pharmaceuticals Source Type: news

AccuTec Blades(R) Announces Exclusive Australia-New Zealand DermaBlade(R) Agreement
Diplomat Blades designated as distributor of shave biopsy blade VERONA, Va., Dec. 5, 2017 -- (Healthcare Sales & Marketing Network) -- AccuTec Blades, Inc., a leader in specialty blade manufacturing, has entered into an agreement with Diplomat Blades t... Devices, Dermatology, Oncology, Distribution AccuTec Blades, DermaBlade, shave biopsy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 5, 2017 Category: Pharmaceuticals Source Type: news

PMV Pharma Appoints Winston Kung as COO and CFO
CRANBURY, N.J., Dec. 5, 2017 -- (Healthcare Sales & Marketing Network) -- PMV Pharmaceuticals, Inc., a leader in the discovery and development of p53-targeted small molecule drugs for the treatment of cancer, today announced the appointment of industry ve... Biopharmaceuticals, Oncology, Personnel PMV Pharmaceuticals, p53 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 5, 2017 Category: Pharmaceuticals Source Type: news

OncoSec Announces Promotion of Christopher G. Twitty, Ph.D. to Chief Scientific Officer
SAN DIEGO, Dec. 5, 2017 -- (Healthcare Sales & Marketing Network) -- OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, today announced the promotion of Christopher G. Twitty, Ph.D.... Biopharmaceuticals, Oncology, Personnel OncoSec Medical, ImmunoPulse, immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 5, 2017 Category: Pharmaceuticals Source Type: news

EMD Serono Announces FDA 510(k) Clearance of Partner Genea Biomedx's Fertility Benchtop Incubator Geri(TM)
Expanded Fertility Technology portfolio highlights EMD Serono's commitment to improve fertility treatment outcomes for patients U.S. commercial availability expected in first half of 2018 ROCKLAND, Mass., Dec. 5, 2017 -- (Healthcare Sales & Marketing... Devices, FDA EMD Serono, Merck KGaA, Genea Biomedx, Geri , Gidget (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 5, 2017 Category: Pharmaceuticals Source Type: news

Astellas Appoints João Carlos de Britto as General Manager of Astellas Farma Brasil
NORTHBROOK, Ill., Dec. 4, 2017 -- (Healthcare Sales & Marketing Network) -- Astellas today announced that João Carlos de Britto has been named general manager of Astellas Farma Brasil (AFB). He will report to Percival Barretto-Ko, senior vice presi... Biopharmaceuticals, Personnel Astellas, Astellas Farma Brasil (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 4, 2017 Category: Pharmaceuticals Source Type: news

Spruce Biosciences Receives FDA Orphan Drug Designation for SPR001 for the Treatment of Congenital Adrenal Hyperplasia
Clinical-stage biotech granted orphan drug designation for the treatment of CAH, a rare endocrine disease SAN FRANCISCO, Dec. 4, 2017 -- (Healthcare Sales & Marketing Network) -- Spruce Biosciences, a clinical-stage biotechnology company developing nov... Biopharmaceuticals, FDA Spruce Biosciences, congenital adrenal hyperplasia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 4, 2017 Category: Pharmaceuticals Source Type: news

Led by OrbiMed Israel and Peter Thiel, ChemomAb Raises $10 Million in Series B Funding
SBI Japan-Israel Innovation Fund and Milestone Participate in Investment Round TEL AVIV, Israel, Dec. 4, 2017 -- (Healthcare Sales & Marketing Network) -- ChemomAb, the bio-pharmaceutical start-up, has completed a $10 million fund raising round led by ... Biopharmaceuticals, Venture Capital ChemomAb, monoclonal antibodies (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 4, 2017 Category: Pharmaceuticals Source Type: news

Dr. Adam Lewis to Adopt EOI's FLXfit(TM) Articulated and Expandable Cages as His Treatment of Choice for MIS TLIF
FLXfit and FLXfit15 are game-changers in Dr. Lewis' leading MIS practice OR AKIVA, Israel, Dec. 4, 2017 -- (Healthcare Sales & Marketing Network) -- Expanding Orthopedics Inc. (EOI), a privately held medical device company focused on developing and com... Devices, Orthopaedic, Neurosurgery Expanding Orthopedics, FLXfit 3D, Expandable Cage, spine surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 4, 2017 Category: Pharmaceuticals Source Type: news

Mylan and Aspen Announce Launch of Generic Busulfex(R) Injection
HERTFORDSHIRE, England, PITTSBURGH and DURBAN, South Africa, Dec. 4, 2017 -- (Healthcare Sales & Marketing Network) -- Mylan N.V. (NASDAQ, TASE: MYL) and its partner, Aspen (JSE: APN), today announced the U.S. launch of Myleran (busulfan) Injection, 60 mg... Biopharmaceuticals, Oncology, Generics, Product Launch Mylan, Otsuka Pharmaceutical, Myleran, busulfan (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 4, 2017 Category: Pharmaceuticals Source Type: news

Merck's Mavenclad (Cladribine Tablets) Approved for Relapsing-Remitting Multiple Sclerosis in Canada
First oral short-course treatment for relapsing- remitting multiple sclerosis (RRMS) now approved in Canada, which has one of the highest rates of MS in the world[1] Mavenclad has shown sustained clinical efficacy with a duration of oral treatment of 20... Biopharmaceuticals, Neurology, Regulatory Merck, Cladribine, MAVENCLAD, multiple sclerosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 4, 2017 Category: Pharmaceuticals Source Type: news

FDA approves first biosimilar for the treatment of certain breast and stomach cancers
Ogivri, a biosimilar to the cancer drug Herceptin, is approved for HER2+ breast cancer and metastatic stomach cancers SILVER SPRING, Md., Dec. 1, 2017 -- (Healthcare Sales & Marketing Network) -- The U.S. Food and Drug Administration today approved Ogiv... Biopharmaceuticals, Oncology, FDA Mylan, Ogivri, trastuzumab-dkst, breast cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 1, 2017 Category: Pharmaceuticals Source Type: news

TesoRx Pharma And ASKA Pharmaceutical Expand Territory And Scope Of Partnering Agreement For TesoRx's Oral Testosterone Product
ASKA makes Equity Investment into TesoRx SAN FRANCISCO and TOKYO, Dec. 1, 2017 -- (Healthcare Sales & Marketing Network) -- TesoRx Pharma LLC and ASKA Pharmaceutical Co., Ltd. announced today they have expanded their existing collaboration to develop a... Biopharmaceuticals, Distribution TesoRx Pharma, ASKA Pharmaceutical, Testosterone (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 1, 2017 Category: Pharmaceuticals Source Type: news

Elekta Introduces New Commercial Name for MEG Business and Reveals New System for Studying Brain Activity at 2017 American Epilepsy Society Meeting
WASHINGTON, December 1, 2017 -- (Healthcare Sales & Marketing Network) -- At the American Epilepsy Society (AES) Annual Meeting in Washington, DC (December 1-5), Elekta (booth #1207) announced that the new commercial name for its MEG business is MEGIN and... Devices, Radiology, Neurology, Product Launch Elekta, magnetoencephalography, TRIUX neo, epilepsy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 1, 2017 Category: Pharmaceuticals Source Type: news

EMD Serono Appoints Zhen Su, M.D., MBA to Chief Medical Officer, North America
ROCKLAND, Mass., Dec. 1, 2017 -- (Healthcare Sales & Marketing Network) -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, today announced the appointment of Zhen Su, M.D., MBA as Chief Medical Officer fo... Biopharmaceuticals, Personnel EMD Serono, Merck KGaA (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 1, 2017 Category: Pharmaceuticals Source Type: news

Bayer and the Broad Institute of MIT and Harvard Expand Partnership to Advance Drug Discovery Research for Novel Cancer Treatments
CAMBRIDGE, Mass. and WHIPPANY, N.J., Dec. 1, 2017 -- (Healthcare Sales & Marketing Network) -- Bayer and the Broad Institute of MIT and Harvard announced today that they have extended their multi-disciplinary research partnership by an additional five yea... Biopharmaceuticals, Oncology Bayer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 1, 2017 Category: Pharmaceuticals Source Type: news

RICOH MEG Receives FDA 510(k) Clearance
TUSTIN, Calif., Nov. 30, 2017 -- (Healthcare Sales & Marketing Network) -- Ricoh today announced that the RICOH MEG Measurement System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). RICOH MEG, Ricoh's magnetoencephalogr... Devices, Radiology, Neurology, FDA Ricoh, MEG Measurement System, magnetoencephalography (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 30, 2017 Category: Pharmaceuticals Source Type: news

Mitsubishi Tanabe Pharma America Announces Addition of RADICAVA(R) (edaravone) to U.S. Department of Veterans Affairs National Formulary
JERSEY CITY, N.J., Nov. 30, 2017 -- (Healthcare Sales & Marketing Network) -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) announced today that the U.S. Department of Veterans Affairs (VA) has added RADICAVA® (edaravone) to its National Formulary (VA... Biopharmaceuticals, Neurology, Reimbursement Mitsubishi Tanabe Pharma, RADICAVA, edaravone, amyotrophic lateral sclerosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 30, 2017 Category: Pharmaceuticals Source Type: news

Cordis and Medinol Announce FDA Approval of the Innovative EluNIR Drug-Eluting Stent System
EluNIR is shown to effectively treat highly complex disease with optimized stent and delivery system DUBLIN, Ohio, Nov. 30, 2017 -- (Healthcare Sales & Marketing Network) -- Cordis, a Cardinal Health company, and Medinol today announced United States F... Devices, Interventional, Cardiology, FDA Cordis, Cardinal Health, Medinol, EluNIR, drug-eluting stent (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 30, 2017 Category: Pharmaceuticals Source Type: news

Epic Sciences Launches Metastatic Breast Cancer Circulating Tumor Cell Panel
Panel provides for the most comprehensive coverage of single-cell biomarkers for clinical trial research SAN DIEGO, Nov. 30, 2017 -- (Healthcare Sales & Marketing Network) -- Epic Sciences, Inc. announces the release of its breast cancer single-cell pr... Diagnostics, Oncology, Product Launch Epic Sciences, circulating tumor cells, breast cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 30, 2017 Category: Pharmaceuticals Source Type: news

Moberg Pharma Reorganizes its Commercial Operations
STOCKHOLM, Nov. 30th, 2017 -- (Healthcare Sales & Marketing Network) -- Moberg Pharma AB (OMX: MOB) is reorganizing its sales and marketing operations to better reflect the company's increased focus on the North American market and to maximize global syne... Biopharmaceuticals, Personnel Moberg Pharma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 30, 2017 Category: Pharmaceuticals Source Type: news